TrialSleep2020

Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy.

Beatrice Setnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.